Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06455449
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2023-09-28
Brief Title:
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies Polymyositis and Dermatomyositis
Sponsor:
AstraZeneca
Organization:
AstraZeneca